Recruitment of a Repressosome Complex at the Growth Hormone Receptor Promoter and Its Potential Role in Diabetic Nephropathy

REFERENCES

• Baxter, R. C., J. M. Bryson, and J. R. Turtle. 1980. Somatogenic receptors of rat liver: regulation by insulin. Endocrinology 107: 1176–1181.
   PubMedGoogle Scholar
• Bellush, L. L., S. Doublier, A. N. Holland, L. J. Striker, G. E. Striker, and J. J. Kopchick. 2000. Protection against diabetes-induced nephropathy in growth hormone receptor/binding protein gene-disrupted mice. Endocrinology 141: 163–168.
   PubMedGoogle Scholar
• Caretti, G., M. C. Motta, and R. Mantovani. 1999. NF-Y associates with H3-H4 tetramers and octamers by multiple mechanisms. Mol. Cell. Biol. 19: 8591–8603.
   PubMedGoogle Scholar
• Cheung, P., C. D. Allis, and P. Sassone-Corsi. 2000. Signaling to chromatin through histone modifications. Cell 103: 263–271.
   PubMed Web of Science ®Google Scholar
• Currie, R. A. 1997. Functional interaction between the DNA binding subunit trimerization domain of NF-Y and the high mobility group protein HMG-I(Y). J. Biol. Chem. 272: 30880–30888.
   PubMedGoogle Scholar
• Currie, R. A. 1998. NF-Y is associated with the histone acetlytransferase GCN5 and P/CAF. J. Biol. Chem. 273: 1430–1434.
   PubMedGoogle Scholar
• de Cavanagh, E. M. V., F. Iinserra, J. Toblli, I. Stella, C. Fraga, and L. Ferder. 2001. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 38: 1130–1136.
   PubMed Web of Science ®Google Scholar
• Edens, A., and F. Talamantes. 1998. Alternative processing of growth hormone receptor transcripts. Endocr. Rev. 19: 559–582.
   PubMed Web of Science ®Google Scholar
• Farsetti, A., M. Narducci, F. Moretti, S. Nanni, R. Mantovani, A. Sacchi, and A. Pontecorvi. 2001. Inhibition of ER alpha-mediated trans-activation of human coagulation factor XII gene by heteromeric transcription factor NF-Y. Endocrinology 142: 3380–3388.
   PubMedGoogle Scholar
• Gorski, K., M. Carneiro, and U. Schibler. 1986. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47: 767–776.
   PubMed Web of Science ®Google Scholar
• Gugliucci, A., and M. Bendayan. 1995. Histones from diabetic rats contain increased levels of advanced glycation end products. Biochem. Biophys. Res. Commun. 212: 56–62.
   PubMedGoogle Scholar
• Izumi, H., C. Molander, L. Z. Penn, A. Ishisaki, K. Kohno, and K. Funa. 2001. Mechanism for the transcriptional repression by c-Myc on PDGF B-receptor. J. Cell. Sci. 114: 1533–1544.
   PubMed Web of Science ®Google Scholar
• Jin, S., and K. W. Scotto. 1998. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 18: 4377–4384.
   PubMed Web of Science ®Google Scholar
• Liberati, C., A. Ronchi, P. Lievens, S. Ottolenghi, and R. Mantovani. 1998. NF-Y organizes the Y-Globin CCAAT boxes region. J. Biol. Chem. 273: 16880–16889.
   PubMedGoogle Scholar
• Liberati, C., R. Sgarra, G. Manifioletti, and R. Mantovani. 1998. DNA binding of NF-Y: the effect of HMG-I proteins depends upon the CCAAT box. FEBS Lett. 433: 174–178.
   PubMed Web of Science ®Google Scholar
• Maity, S. N., and B. de Crombugghe. 1998. Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends. Biochem. Sci. 23: 174–178.
   PubMedGoogle Scholar
• Manni, I., G. Mazzaro, A. Gurtner, R. Mantovani, U. Haugwitz, K. Krause, K. Engeland, A. Sacchi, S. Soddu, and G. Piaggo. 2001. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J. Biol. Chem. 276: 5570–5576.
   PubMedGoogle Scholar
• Mantovani, R. 1999. The molecular biology of the CCAAT-binding factor NF-Y. Gene 239: 15–27.
   PubMed Web of Science ®Google Scholar
• Menon, R. K., S. Arslanian, B. May, W. S. Cutfield, and M. A. Sperling. 1992. Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 74: 934–938.
   PubMedGoogle Scholar
• Menon, R. K., A. Shaufl, J. H. Yu, D. A. Stephan, and R. P. Friday. 2001. Identification and characterization of a novel transcript of the murine growth hormone receptor gene exhibiting development- and tissue-specific expression. Mol. Cell. Endocrinol. 172: 135–146.
   PubMed Web of Science ®Google Scholar
• Menon, R. K., D. A. Stephan, R. H. Rao, Z. Shen-orr, Jr., L. S. Down, C. T. Roberts, D. LeRoith, and M. A. Sperling. 1994. Tissue-specific regulation of the growth hormone receptor gene in streptozotocin-induced diabetes in the rat. J. Endocrinol. 142: 453–462.
   PubMed Web of Science ®Google Scholar
• Menon, R. K., D. A. Stephan, M. Singh, S. M. Morris, Jr., and L. Zou. 1995. Cloning of the promoter-regulatory region of the murine growth hormone receptor gene: identification of a developmentally regulated enhancer element. J. Biol. Chem. 270: 8851–8859.
   PubMedGoogle Scholar
• Mercado, M., M. E. Molitch, and G. Baumann. 1992. Low plasma growth hormone binding protein in IDDM. Diabetes 41: 605–609.
   PubMedGoogle Scholar
• Munichoodappa, C. S., S. B. Rees, R. F. Bradley, M. C. Balodimos, and G. Boden. 1971. Bragg peak proton beam irradiation of the pituitary gland for proliferative diabetic retinopathy. Ann. Intern. Med. 74: 491–498.
   PubMed Web of Science ®Google Scholar
• Munshi, N., M. Y. Merika, K. Senger, G. Chen, and D. Thanos. 1998. Acetylation of HMG-I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell 2: 457–467.
   PubMed Web of Science ®Google Scholar
• Nakshatri, H., P. Bhat-Nakshatri, and R. A. Currie. 1996. Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J. Biol. Chem. 271: 28784–28791.
   PubMed Web of Science ®Google Scholar
• Philipsen, S., and G. Suske. 1999. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 27: 2991–3000.
   PubMed Web of Science ®Google Scholar
• Shi, Q., K. W. Gross, and C. D. Sigmund. 2001. NF-Y antagonizes renin enhancer function by blocking stimulatory transcription factors. Hypertension 38: 332–336.
   PubMedGoogle Scholar
• Smith, L. E., J. J. Kopchick, W. W. Chen, J. Knapp, F. Kinose, D. Daley, E. Foley, R. G. Smith, and J. M. Schaeffer. 1997. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276: 1706–1709.
   PubMed Web of Science ®Google Scholar
• Sonksen, P. H., D. Russell-Jones, and R. H. Jones. 1993. Growth hormone and diabetes mellitus. Horm. Res. 40: 68–79.
   PubMed Web of Science ®Google Scholar
• Sterner, D. E., and S. L. Berger. 2000. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64: 435–459.
   PubMed Web of Science ®Google Scholar
• Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403: 41–45.
   PubMed Web of Science ®Google Scholar
• West, I. C. 2000. Radicals and oxidative stress in diabetes. Diabet. Med. 17: 171–180.
   PubMed Web of Science ®Google Scholar
• Yu, J. H., G. Schwartzbauer, A. Kazlman, and R. K. Menon. 1999. Role of the Sp family of transcription factors in the ontogeny of growth hormone receptor gene expression. J. Biol. Chem. 274: 34327–34336.
   PubMedGoogle Scholar
• Zhang, J.-S., M. C. Moncrieffe, J. Kaczynski, V. Ellenrieder, F. G. Prendergast, and R. Urrutia. 2001. A conserved alpha-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A. Mol. Cell. Biol. 21: 5041–5049.
   PubMedGoogle Scholar
• Zou, L., and R. K. Menon. 1995. A member of the CTF/NF-1 transcription factor family regulates murine growth hormone receptor gene promoter activity. Endocrinology 136: 5236–5239.
   PubMedGoogle Scholar